Medical Image Analysis Software Market

The global medical image analysis software market is expected to grow from USD 4.35 billion in 2026 to USD 6.42 billion by 2031, at a CAGR of 8.1% during the forecast period. Growth is being driven by the increasing adoption of AI-enabled image analysis for automated detection, segmentation, reconstruction, quantification, and clinical decision support across radiology and other imaging-intensive specialties. According to the US FDA, AI-enabled medical devices are increasingly used for image acquisition and processing, early disease detection, diagnosis, prognosis, and risk assessment. The FDA’s AI-enabled device list includes numerous radiology applications from major imaging companies and specialized AI developers. The market is also supported by the growing integration of AI directly into imaging workflows. In January 2026, Siemens Healthineers’ AI-Rad Companion Brain MR received FDA 510(k) clearance, adding automated radiological image-processing capabilities to its portfolio. Siemens describes AI-Rad Companion as a cloud-based platform that automates repetitive post-processing, highlights abnormalities, segments anatomy, and generates quantitative results for physician review. In 2025, GE HealthCare also expanded its AI-enabled imaging portfolio, including SIGNA One, an ecosystem of AI-enabled workflow solutions designed to streamline MR operations. Philips, meanwhile, reported in its 2025 Annual Report that its imaging portfolio included AI-powered MRI and the AI-powered Verida spectral CT platform, supporting diagnostic precision and operational efficiency.

The major players operating in this market include Siemens Healthineers AG (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), FUJIFILM Holdings Corporation (Japan), Agfa HealthCare (Belgium), Carestream Health, Inc. (US), Hologic, Inc. (US), Merative (US), Sectra AB (Sweden), Bruker Corporation (US), MIM Software Inc. (US), Mirada Medical Ltd. (UK), Median Technologies (France), Aidoc Medical Ltd. (Israel), RapidAI, Inc. (US), Microsoft Corporation (US), Tempus AI, Inc. (US), NANO-X Imaging Ltd. (Israel), and ContextVision AB (Sweden), among others. These companies are focusing on AI-based detection and diagnosis software, cloud-enabled enterprise imaging, reconstruction and visualization tools, radiology workflow automation, and disease-specific analysis across cardiology, oncology, and neurology. In November 2025, GE HealthCare agreed to acquire Intelerad, a medical imaging software provider, for USD 2.3 billion in cash to expand its cloud-enabled and AI-powered enterprise imaging offerings. Siemens Healthineers AG (Germany) continues to position its radiology services suite around AI-enabled image interpretation, covering scheduling, image acquisition, and automated reporting. AI-native providers are also reshaping the market; in April 2026, Aidoc Medical Ltd. (Israel) raised USD 150 million in Series E funding led by Goldman Sachs Alternatives to expand its clinical AI foundation model into new disease areas, while GE HealthCare separately agreed in September 2025 to acquire icometrix, a company building AI software for brain MRI analysis in neurological disease.

To know about the assumptions considered for the study download the pdf brochure

Siemens Healthineers AG (Germany) is one of the world's largest medical imaging companies, with a strong presence in CT, MRI, and AI-powered image analysis software. In fiscal 2025, which ended September 30, 2025, the company had around 74,000 employees and generated revenue of about €23.4 billion. In November 2025, Siemens Healthineers launched a new AI-enabled radiology services suite covering the full imaging chain, from scheduling to image acquisition to reporting, including tools that automatically summarize clinically relevant findings for radiologists. At RSNA 2025, the company also introduced Syngo.CT Coronary Cockpit, AI software that reads heart CT scans to detect coronary artery disease and help plan treatment. Siemens' strength lies in combining its large installed base of scanners with software that helps hospitals read scans faster and more accurately.

GE HealthCare (US) is a major supplier of imaging hardware and software and has been expanding aggressively into AI-based image analysis through acquisitions. In November 2025, GE HealthCare announced it would acquire Intelerad, a medical imaging software company, for USD 2.3 billion in cash, to expand its cloud-based and AI-powered imaging tools. The deal was completed in March 2026, adding enterprise imaging software used across hospitals, outpatient clinics, and teleradiology providers. Earlier, in September 2025, GE HealthCare had also agreed to acquire icometrix, a company that makes AI software for analyzing brain MRI scans in conditions like Alzheimer's disease. These deals show GE HealthCare's push to build a connected, AI-driven imaging software business alongside its scanner hardware.

Aidoc Medical Ltd. (Israel) is a fast-growing AI company focused entirely on medical image analysis software, rather than imaging hardware. In April 2026, Aidoc secured USD 150 million in Series E funding, led by Goldman Sachs Alternatives, bringing its total funding to over USD 500 million. The company holds the most US FDA clearances for computer-aided detection software in the industry and reports that its AI reviews scans for more than 60 million patients annually. Aidoc's press release highlighted that diagnostic errors and delays contribute to at least 400,000 deaths each year in the US, and the company claims its AI platform is designed to help prevent these tragedies. The new funding will be used to expand its CARE foundation model into additional disease areas such as oncology and cardiology.

MARKET RANKING

In the medical image analysis software market, the top five players, Siemens Healthineers AG (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), and FUJIFILM Holdings Corporation (Japan), together hold around 50–60% of the global market. The market is moderately consolidated at the top because these five companies combine large installed bases of CT, MRI, and ultrasound hardware with their own AI-powered image analysis software, giving them an advantage over standalone software vendors. Other notable players include Agfa HealthCare (Belgium), Carestream Health, Inc. (US), Hologic, Inc. (US), Merative (US), Sectra AB (Sweden), Aidoc Medical Ltd. (Israel), RapidAI, Inc. (US), and Microsoft Corporation (US), which compete through specialized AI algorithms, cloud-based imaging platforms, and enterprise workflow software.

Siemens Healthineers AG and GE HealthCare are among the strongest players because of their scale and continuous AI investment. Siemens Healthineers generated around EUR 23.4 billion in revenue in fiscal 2025 and has built its imaging software business around AI-enabled reporting and reconstruction tools. GE HealthCare, a USD 20.6 billion business, strengthened its imaging software portfolio in November 2025 by agreeing to acquire Intelerad for USD 2.3 billion in cash, expanding into cloud-based enterprise imaging. Koninklijke Philips N.V. is also a major player, having unveiled Philips Verida, described as the world's first detector-based Spectral CT fully powered by AI, at RSNA in late 2025. Canon Medical Systems Corporation and FUJIFILM Holdings Corporation support the market through advanced CT/MRI reconstruction software, AI-based diagnostic imaging tools, and strong distribution across hospitals in Japan, North America, and Europe. These companies are strengthening their positions by combining deep imaging hardware expertise with AI software, cloud deployment, and workflow integration. However, no single company dominates the market, as demand spans multiple modalities, therapeutic areas, and end users, including hospitals, diagnostic imaging centers, and research institutions.

Related Reports:

Medical Image Analysis Software Market by Function (Reconstruction, Detection, Analysis, Reporting), Tech (AI [ML, Computer Vision), Image (3D, 4D), Modality (CT, PET/SPECT, Mammo), Indication (Onco, Cardio), End User (Hospital) - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]